[Gentamicin therapy of infectious diseases by pathogens (author's transl)].
Gentamicin (GM) was intramuscularly injected to 29 patients with various infections in the doses of 40-60 mg twice a day. The maximum dose was 1,800 mg. Satisfactory clinical results were obtained in the treatment of not only urinary tract infections but also respiratory tract infections, bile duct infections and others. This clinical results would coincide with the fact that almost all organisms isolated had a high sensitivity to GM. No significant abnormal findings was observed in this clinical study. This clinical result indicates that GM is a useful drug in the treatment of various infections.
D000328:Adult; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002764:Cholecystitis / Q000188:drug therapy; D003556:Cystitis / Q000188:drug therapy; D004653:Empyema / Q000188:drug therapy; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy; D003668:Pressure Ulcer / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D005839:Gentamicins